Cargando…
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
BACKGROUND: Changes in driving behaviour may start at the preclinical stage of Alzheimer’s disease (AD), where the underlying AD biological process has begun in the presence of cognitive normality. Here, we summarize the emerging evidence suggesting that preclinical AD may impact everyday driving be...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641948/ https://www.ncbi.nlm.nih.gov/pubmed/36348410 http://dx.doi.org/10.1186/s13195-022-01109-1 |